Gerald Lewis Kaplan - New York NY Achyutharao Sidduri - Livingston NJ Jefferson Wright Tilley - North Caldwell NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07D21172
US Classification:
546291
Abstract:
Compounds of Formula I have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4 and are useful for treating disease whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
Compounds of Formula I have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4 and are useful for treating disease whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
Mirjana Andjelkovic - Basel, CH Simona M. Ceccarelli - Basel, CH Odile Chomienne - Altkirch, FR Gerald Lewis Kaplan - New York NY, US Patrizio Mattei - Riehen, CH Jefferson Wright Tilley - North Caldwell NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 31/195 C07C 229/00
US Classification:
514563, 562561, 562564
Abstract:
This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula.
Compounds of Formula I have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4 and are useful for treating disease whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
Mirjana Andjelkovic - Basel, CH Simona M. Ceccarelli - Basel, CH Odile Chomienne - Altkirch, FR Gerald Lewis Kaplan - New York NY, US Patrizio Mattei - Riehen, CH Jefferson Wright Tilley - North Caldwell NJ, US
This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formulawherein A, A, R, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments in methods for the treatment of diseases modulated by CPT2 inhibitors.
An apparatus for automatically monitoring the respiration of a subject requiring no physical connection to the subject. The use of such apparatus for automatically triggering an x-ray machine at instants of respiration extrema is also disclosed.
Fred Sterzer - Princeton NJ Gerald Stanley Kaplan - Lawrenceville NJ
Assignee:
RCA Corporation - New York NY
International Classification:
G01S 956 G01S 946
US Classification:
343 6R
Abstract:
A frequency-modulated continuous-wave collision avoidance radar responsive to both reply signals from cooperating (tagged) targets and to skin reflections from proximate non-cooperating (non-tagged) targets.
Adaptive Parameter Processor For Continuous Wave Radar Ranging Systems
An adaptive parameter signal processor for continuous wave radar ranging systems which provides non-quantized measurements of range. Means are provided to select a suitable portion of the difference frequency wave form, excluding any phase reversal. The period of the difference frequency is measured using the selected portion of the waveform and is converted to frequency. The frequency is, in turn, converted to range. The system parameters are automatically adjusted in accordance with the difference frequency waveform.